Who Exports Gemcitabine from India β 248 Suppliers Behind a $46.5M Market
India's gemcitabine export market is supplied by 248 active exporters who collectively shipped $46.5M across 2,938 shipments. FRESENIUS KABI ONCOLOGY LIMITED leads with a 14.8% market share, followed by EUGIA PHARMA SPECIALITIES LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED. The top 5 suppliers together control 55.8% of total export value, reflecting a moderately competitive market structure.

Top Gemcitabine Exporters from India β Ranked by Export Value
FRESENIUS KABI ONCOLOGY LIMITED is the leading gemcitabine exporter from India, holding a 14.8% share of the $46.5M market across 2,938 shipments from 248 exporters. The top 5 suppliers β FRESENIUS KABI ONCOLOGY LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED β collectively control 55.8% of total export value, indicating a moderately concentrated market. Individual shares are: FRESENIUS KABI ONCOLOGY LIMITED (14.8%), EUGIA PHARMA SPECIALITIES LIMITED (12.7%), SUN PHARMACEUTICAL INDUSTRIES LIMITED (12.5%), MYLAN LABORATORIES LIMITED (8.0%), INTAS PHARMACEUTICALS LIMITED (7.9%).
Top Gemcitabine Exporters from India
Ranked by export value Β· 248 active suppliers Β· Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 |